Clear Perspective Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Clear Perspective Advisors's GILD Position: Q4 2021 in Review
Clear Perspective Advisors reduced its Gilead Sciences (GILD) stake by 11% in Q4 2021, selling an estimated $24.8K and leaving 2,980 shares worth $216K. The position accounts for 0.07% of the portfolio, ranked #167.
Clear Perspective Advisors first reported a position in GILD in Q4 2016 and has held it in 18 quarters since. The position peaked at $680K in Q1 2019. 1,683 funds tracked by Wall St. Rank hold GILD as of Q4 2021.
- Clear Perspective Advisors held 2,980 shares of Gilead Sciences worth $216K as of Q4 2021.
- Clear Perspective Advisors sold 360 Gilead Sciences shares in Q4 2021, an estimated $24.8K.
- Gilead Sciences made up 0.07% of Clear Perspective Advisors's portfolio in Q4 2021, its #167 holding.
- Clear Perspective Advisors first reported a position in Gilead Sciences in Q4 2016 and has held it in 18 quarters since.
- Clear Perspective Advisors's Gilead Sciences position peaked at $680K in Q1 2019.
- 1,683 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2021.
Based on Clear Perspective Advisors's 13F filing for Q4 2021, filed 17 Feb 2022.